Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulating Ventral Striatal Activity and Connectivity With Transcranial Focused Ultrasound as a Putative Novel Intervention for Cocaine Use Disorder

NCT07852923 is registered in ClinicalTrials.gov with Mary Phillips, MD MD (Cantab) as lead sponsor.

NCT NCT07852923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07852923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulating Ventral Striatal Activity and Connectivity With Transcranial Focused Ultrasound as a Putative Novel Intervention for Cocaine Use Disorder
Lead sponsor
Mary Phillips, MD MD (Cantab)
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 15, 2026
Completion date
December 15, 2028
Enrollment
57 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine use disorder (cud)